Key result
Lithotripsy temporarily inhibits ~50% of pacemakers during asynchronous shocks without causing permanent device damage.
Why the study?
The impact of extracorporeal shock wave lithotripsy on cardiac pacemakers, arterial calcifications, and vascular clips was investigated due to potential safety concerns.
Answers are grounded in this paper and cite their sources.
Bench testing shows reversible pacemaker inhibition by lithotripsy; leaves open need for in vivo device protocols.
We investigated the impact of extracorporeal shock wave lithotripsy on cardiac pacemakers, arterial calcifications, and vascular clips. When 22 cardiac pacemaker pulse generators mounted five cm. lateral to the focus of the lithotripter were subjected to both synchronous and asynchronous shock waves, one reverted to magnet rate with synchronous shocks and 11 were inhibited by asynchronous shocks. None was damaged or spuriously reprogrammed. In a second experiment, 10 canine and cadaveric aortas and common iliac arteries with metal surgical clips on two to three mm. branches were pressurized with methylene blue in normal saline at 150 mm. Hg and fixed in the Dornier lithotripter. Shock waves (N = 2000; 22 kV) were focused on the surgical clips and no leakage of methylene blue was found.
No takes yet. Share an insight, caveat, or question.
Abber et al. (1988) studied Evaluation of pacemakers, arterial calcifications, and vascular clips. Extracorporeal shock wave lithotripsy was evaluated on Pacemaker damage, reprogramming, or inhibition, and arterial leakage. Extracorporeal shock wave lithotripsy inhibited 11 of 22 pacemakers during asynchronous shocks, but caused no permanent damage, spurious reprogramming, or leakage from surgical clips.
Synapse has enriched 10 related papers. Consider them for comparative context: